Samsara Launches Agentic Tools Amid Growth Deceleration Concerns

What happened

Samsara announced new agentic capabilities including an Agent Studio to automate tedious operational tasks, aiming to strengthen its platform narrative. However, the DeepValue Master Report flags that the stock at $32.57 already prices in sustained high growth, while FY27 guidance implies a deceleration to 21-22% YoY revenue growth. The report maintains a WAIT rating with conviction 3.5, citing risks from longer enterprise sales cycles and a full U.S. deferred-tax valuation allowance that undermines GAAP re-rating. The launch does not address the core thesis driver: whether Samsara can convert enterprise momentum into a guide raise within two quarters. Near-term proof points remain aggressive $100K+ customer adds and emerging products maintaining ~20% of net new ACV.

Implication

Investors should monitor whether the agentic launch accelerates emerging products' ACV contribution and drives a FY27 revenue guide raise above $2.0B. If growth re-accelerates to 24-26%, the bull case ($42) becomes plausible; if growth settles at ~21% without a raise, downside to $24 is likely.

Thesis delta

The agentic launch reinforces the platform breadth narrative but does not change the near-term investment thesis: Samsara's valuation at $32.57 still requires a FY27 revenue guidance raise within two quarters. The new tools could support emerging products' ACV share, but the core risk of deceleration from ~30% to ~21% YoY growth remains unaddressed. Without a tangible acceleration in enterprise adds or large-deal conversions, the stock remains range-bound with downside bias.